Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells

Overview of attention for article published in Journal of Hematology & Oncology, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 86 Dimensions

Readers on

mendeley: 94 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

MODIFIED T CELLS AND USES THEREOF

Application EP-3810756-A4

European Patent Office

MULTISPECIFIC ANTI-FLT3 CHIMERIC ANTIGEN RECEPTORS

Application WO-2021222793-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.